Interestingly, according to studies, in keloid, one of the benign skin tumors [63], ADSCs could reduce the expression of COL1A1 in keloid fibroblasts and deposition of collagen in keloid tissue ex vivo. The gene discussed is COL1A1; the disease is keloid.